Tissue Sectioning Market To Grow At 6.57% CAGR Till 2033
The tissue sectioning market size was exhibited at USD 595.19 million in 2024 and is projected to hit around USD 1,124.63 million by 2034, growing at a CAGR of 6.57% during the forecast period 2024 to 2034.
Tissue Sectioning Market Key Takeaways:
?????????????? ?????? ???????? ???????????? ????????????: https://www.novaoneadvisor.com/report/sample/1797
Rising prevalence of chronic diseases and cancers is one of the crucial factors driving demand for histopathology tests as a tissue pathology examination is of utmost importance for the diagnosis of a malignant tumor. Cancer is considered as one of the leading causes of death worldwide. Analysis of biopsy tissues enables pathologists to determine cancer type, stage, and the degree to which the disease has invaded healthy tissues. This has led to an increased adoption of histopathology and tissue sectioning and staining instruments, in turn propelling the market growth.
Growth of personalized therapeutics and diagnostics is expected to boost the market growth. Personalized medicine is becoming the hallmark of cancer treatment and with its application expanding to other fields. It is a constantly emerging approach toward customizing treatments based on the individual genetic buildup of patients. Rising adoption of personalized medicine has led to an increase in demand for the use of human tissue as the field relies on the use of human tissue for the development of innovative tests.
The rise in awareness programs undertaken by organizations, such as National Cervical Cancer Coalition, World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the U.S. Preventive Services Task Force (USPSTF), for cancer screening, is a crucial factor driving the market growth. Efforts from major market players to undertake initiatives for creating awareness about cervical and vaginal cancer screening is anticipated to bode well for the market growth.
For instance, the National Health Service (NHS) offers cervical screening programs for all women between 25 and 64 years of age in the U.K. Women aged between 25 years and 49 years are generally screened every three years, whereas women aged between 50 years to 64 years are screened every five years. The Norway government initiated the Norwegian Cervical Cancer Screening Programme (NCCSP) offers to screen women between 25 and 69 years, every three years.
Tissue Sectioning Market By Product Insights
In 2024, the instruments segment accounted for over 50% revenue share of the tissue sectioning market. Microtomes and cryostats are required for cutting uniform sections of tissues under study. Advanced versions of microtomes can precisely cut tissue block of thickness ranging from 0.1 to 100 μm. These devices are available in a variety of forms, such as sliding, rotating, freezing, ultra, and laser microtomes. Therefore, the availability of a wide range of products to serve different purposes in pathology labs is expected to drive the segment growth.
Tissue Sectioning Market By Technology Insights
The automatic technology segment accounted for the largest market share in 2024 owing to a growing demand for technologically advanced products in developed and developing economies including Germany, U.S., Japan, France, and others. The segment is also anticipated to register the fastest CAGR over the forecast period. Automatic microtomes provide users with the utmost benefit, reliability, and excellent operator comfort. The precision and high section scalability offered by automatic microtomes make these instruments an ideal choice for sectioning of paraffin-embedded tissues and hard materials. Therefore, automatic instruments are readily adopted in the field of diagnostics, medicine, and other research purposes. Key market players have made significant R&D investments to upgrade the product features and make it user-friendly. For instance, feather touch buttons installed on the device make working efficient and effortless. Some of the key automated products include Tissue-Tek AutoSection, Tissue Surgeon, and PT-PC PowerTomes.
Tissue Sectioning Market By Application Insights
Disease diagnosis segment dominated the market in 2024. The medical research segment is expected to expand at the fastest CAGR during the forecast period. Histopathological examination of surgical biopsies is considered as a standard method for the diagnosis of various disorders, including cancer. Hence, the method is readily adopted by pathological laboratories across the globe.
Researchers have developed several recommendations to enhance the quality of the tissue specimen used for biopsy during clinical trials. This is because tissue samples for tumor biopsy can be helpful for medical research as it can provide relevant information regarding the behavior of cancer drugs within the human body. Such initiatives are expected to enhance the growth of the medical research segment.
Tissue Sectioning Market By End-use Insights
Tissue sectioning is employed in hospitals, small clinics, diagnostic laboratories, and research centers for the analysis of biopsy specimens and other tissues. Hospitals segment accounted for the largest market share of 40.0% in 2024, owing to a high inflow of biopsy specimens for histopathology and cytopathology, and a rise in the number of hospital admission for cancer patients.
Tissue Sectioning Market By Regional Insights
North America held the dominant revenue share of the market for tissue sectioning in 2024 owing to advanced healthcare infrastructure, increasing investment by the public and private sectors in tissue diagnostics, and high adoption of technologically advanced fully automated products. Rise in the prevalence of cancer in North America boosts the demand for biopsies for cancer diagnosis leading to an increased demand for tissue sectioning equipment.
Asia Pacific is expected to witness the fastest CAGR during the forecast period. The presence of a huge target population, high unmet clinical needs coupled with growing R&D activities for advanced diagnostic techniques are projected to propel the growth of the regional market. In addition, improvement in the healthcare infrastructure and rise in healthcare expenditure is anticipated to provide a potential growth platform for the key manufacturers. Rising penetration of medical insurance in countries like India and China is a significant market driver. In addition, the presence of prominent players including SM Scientific Instruments Pvt. Ltd., AGD Biomedicals, and Amos Scientific Pty. Ltd. in countries like India and Australia is expected to drive the regional market.
Some of the prominent players in the tissue sectioning market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the tissue sectioning market
Product
By Technology
By Application
By End-use
By Regional
Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/1797
Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com
You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333
About US
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
Connect with Us
Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
IND Address: 707, Nandan Probiz, Baner,?Pune (MH) – 411045, India
USA:?+1 804 441 9344
APAC:?+61 485 981 310 or +91 87933 22019
Europe:?+44 7383 092 044
Email: [email protected]
You can place an order or ask any questions, please feel free to contact at?[email protected] ?| +1 804 441 9344
Nova One Advisor Group Offer Other Reports:
Cell Therapy Market Size and Forecast:?The global?cell therapy market size was exhibited at USD 4.85 billion in 2023 and is projected to hit around USD 37.42 billion by 2033, growing at a CAGR of 22.67% during the forecast period 2024 to 2033.
Gene Therapy Market Size and Forecast?:?The global?gene therapy market size was exhibited at USD 8.75 billion in 2023 and is projected to hit around USD 52.40 billion by 2033, growing at a CAGR of 19.6% during the forecast period 2024 to 2033.
Cell And Gene Therapy Manufacturing Market Size and Forecast:?The global?cell and gene therapy manufacturing market size was estimated at USD 9.95 billion in 2023 and is projected to hit around USD 106.03 billion by 2033, growing at a CAGR of 26.7% during the forecast period from 2024 to 2033.
Cell and Gene Therapy Market?Size and Forecast:?The global?cell and gene therapy market size was estimated at USD 18.13 billion in 2023 and is projected to hit around USD 97.33 billion by 2033, growing at a CAGR of 18.3% during the forecast period from 2024 to 2033.
U.S. Cell Therapy Market Size and Forecast:?The?U.S. cell therapy market size was estimated at USD 2.88 billion in 2023 and is projected to hit around USD 19.67 billion by 2033, growing at a CAGR of 21.18% during the forecast period from 2024 to 2033.
U.S. Gene Therapy Market Size and Forecast:?The?U.S. gene therapy market size?was estimated at USD 3.19 billion in 2023 and is projected to hit around USD 18.50 billion by 2033, growing at a CAGR of 19.22% during the forecast period from 2024 to 2033.
T-cell Therapy Market Size and Forecast:?The global?T-Cell therapy market size?was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 79.62 billion by 2033, growing at a CAGR of 35.38% during the forecast period 2024 to 2033.
Cancer Immunotherapy Market?Size and Forecast:?The global?cancer immunotherapy market?size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.
Immunotherapy Drugs Market?:?The global?immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.
Clinical Trials Market Size and Forecast:?The?global clinical trials market size was estimated at USD 81.90 billion in 2023 and is projected to hit around USD 153.59 billion by 2033, growing at a CAGR of 6.49% during the forecast period from 2024 to 2033.
Biologics Market Size and Forecast: The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.
Biotechnology Market Size and Forecast:? The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.
Oncology? Market Size and Forecast: The?global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.
Cell And Gene Therapy Clinical Trials?Market Size and Forecast: The global cell and gene therapy clinical trials market size reached USD 11.62 billion in 2023 and is projected to hit around USD 47.40 billion by 2033, expanding at a CAGR of 15.09% during the forecast period from 2024 to 2033.
U.S. Clinical Trials Market Size and Forecast:?The?U.S. clinical trials market size was valued at USD 25.81 billion in 2023 and is projected to surpass around USD 41.57 billion by 2033, registering a CAGR of 4.88% over the forecast period of 2024 to 2033.
Active Pharmaceutical Ingredient CDMO Market:?The global active pharmaceutical ingredient CDMO market size was valued at USD 119.80 billion in 2023 and is anticipated to reach around USD 249.22 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.
U.S. Pharmaceutical Market?:?The U.S. pharmaceutical market size was valued at USD 602.19 billion in 2023 and is projected to surpass around USD 1,093.79 billion by 2033, registering a CAGR of 6.15% over the forecast period of 2024 to 2033.
Viral Vector And Plasmid DNA Manufacturing Market:?The global viral vector and plasmid DNA manufacturing market size?was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 39.30 billion by 2033, growing at a CAGR of 20.3% from 2024 to 2033.
U.S. Viral Vector And Plasmid DNA Manufacturing Market ;?The U.S. viral vector and plasmid DNA manufacturing market size was valued at USD 2.45 billion in 2023 and is expected to be worth around USD 15.30 billion by 2033, with a registered CAGR of 20.1% during forecast period 2024 to 2033.
Compounding Pharmacies Market :?The global compounding pharmacies market size?was valued at USD 16.19 billion in 2023 and is anticipated to reach around USD 30.97 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033.
U.S. Compounding Pharmacies Market?:?The U.S. compounding pharmacies market size?is projected to be worth around USD 10.76 billion by 2033 from USD 6.31 billion in 2024, at a CAGR of 6.1% from 2024 to 2033.
Antibiotics Market: The?global antibiotics market size?was valued at USD 51.19 billion in 2023 and is projected to surpass around USD 85.80 billion by 2033, registering a CAGR of 5.3% over the forecast period of 2024 to 2033.
Biologics Market :?The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.
Biotechnology Market:?The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.
Next Generation Sequencing Market?:?The?global next generation sequencing market size was estimated at USD 9.19 billion in 2023 and is projected to hit around USD 66.04 billion by 2033, growing at a CAGR of 21.8% during the forecast period from 2024 to 2033.
Genome Editing Market ;?The?global genome editing market size?was valued at USD 8.45 billion in 2023 and is anticipated to reach around USD 40.48 billion by 2033, growing at a CAGR of 16.96% from 2024 to 2033.
U.S. Genome Editing Market:?The?U.S. genome editing market size was estimated at USD 3.55 billion in 2023 and is projected to hit around USD 16.49 billion by 2033, growing at a CAGR of 16.6% during the forecast period from 2024 to 2033.
U.S. Gene Synthesis Market?:?The?U.S. Gene Synthesis market size was valued at USD 700.90 million in 2023 and is projected to surpass around USD 3,118.73 million by 2033, registering a CAGR of 16.1% over the forecast period of 2024 to 2033.
Biopharmaceutical Market :?The global?Biopharmaceutical market size accounted for USD 327.46 billion in 2022 and is estimated to achieve a market size of USD 1,101.77 billion by 2032 growing at a CAGR of 12.9% from 2023 to 2032.
Immunotherapy Drugs Market?:?The?global immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.
Cancer Immunotherapy Market:?The global cancer immunotherapy market size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.
U.S. Plasmid DNA Manufacturing Market?:?The U.S. plasmid DNA manufacturing market size?was valued at USD 711.90 million in 2023 and is projected to surpass around USD 4,885.15 million by 2033, registering a CAGR of 21.24% over the forecast period of 2024 to 2033.
U.S. Precision Medicine Market?:?The?U.S. precision medicine market size was valued at USD 24.95 billion in 2023 and is projected to reach around USD 76.12 billion by 2033, registering a CAGR of 11.80% from 2024 to 2033.